Diabetes
Relevant Content
2026 Heart Disease and Stroke Statistics
Cerebral Artery Ectasia in Brucella
Putting Evidence Into Practice: Tips For Starting and Continuing GLP-1 RAs
Barriers to GLP-1 RAs
AHA and NIH’s 2026 Statistics Update delivers the latest U.S. data on hear...
Proteomic Signatures of Cardiac Dysfunction Among People With Diabetes: The Atherosclerosis Risk in Communities Study
Circulation: Heart Failure, Ahead of Print.
BACKGROUND:To investigate...
A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes
BACKGROUND:To investigate...
Circulation Research, Volume 138, Issue 2, Page e325798, January 16, 2026....
Letter by Zhao Regarding Article, “Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial”
Circulation, Volume 153, Issue 2, Page e8-e9, January 13, 2026.
Glucagon-Like Peptide-1 Receptor Agonists and Decreased Subarachnoid Hemorrhage Risk in Patients With Intracranial Aneurysm
Stroke, Ahead of Print.
BACKGROUND:The potential protective effect of...
Beyond the Numbers: Personal Journeys with Hyperlipidemia and ASCVD
BACKGROUND:The potential protective effect of...
Stroke, Volume 57, Issue 1, Page e8-e9, January 1, 2026.
Cardiovascular Benefits of GLP-1 RAs
